Correction

In the last edition (June/July 2011), the article “Advair and Flovent move to non-preferred” showed Alvesco and Asmanex as Tier 2 options on our employer-sponsored formulary. The chart should have listed Alvesco and Asmanex as Tier 3 options.

Topics: Priority Health updates